CD93 and cancer: Zhang et al. synthesized data from various sources, largely supporting prior analyses, and noted that CD93 overexpression is associated with poor prognosis in cancers like LGG, ovarian serous cystadenocarcinoma (OV), KIRP, and LUSC.